(WTAE) A BMJ investigation resurfaced old doubts about the PLATO trial of ticagrelor (Brilinta), while raising new questions about the possibility of unblinding in the study. Researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback